The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects

耐受性 药代动力学 药理学 医学 药效学 加药 人口 Janus激酶抑制剂 不利影响 内科学 贾纳斯激酶 受体 环境卫生
作者
Jiaying Wang,Ying‐hui Gao,Zourong Ruan,Dandan Yang,Hua Li,Shida Qiao,Jian‐hui Li,Xin You,Jun Yi Shi,Bo Jiang
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:65 (11): 1474-1484
标识
DOI:10.1002/jcph.70053
摘要

Abstract QY201 is a dual inhibitor targeting Janus Kinase 1/Tyrosine Kinase 2, developed for the treatment of atopic dermatitis and other autoimmune diseases. The pharmacokinetics (PK), pharmacodynamics (PD), tolerability, and safety of QY201 were assessed in a randomized, double‐blind study in healthy subjects. Population PK and PD models were developed to characterize the PK and PD of QY201. QY201 was absorbed and eliminated rapidly, and the exposure was approximately dose‐proportional over the 1‐40 mg dose range, with no significant accumulation after repeated dosing. A high‐fat meal reduced the maximum plasma concentration of QY201 by 40.7% but did not affect the area under the concentration‐time curve. The fraction of the QY201 dose eliminated in the urine unchanged was 22%. In the multiple ascending‐dose phase, the reduction of hypersensitive C‐reactive protein (hsCRP) and absolute neutrophil count (ANC) showed dose‐dependent trends within certain doses. The PK of QY201 was best described by a 2‐compartment model with first‐order absorption and elimination. The hsCRP was best described by an indirect response maximum drug effect (E max ) model. QY201 was generally safe and well tolerated following oral administration, with dose‐limiting toxicity of the highest tested dose of 40 mg being well tolerated. The favorable PK, PD, safety, and tolerability results from these studies supported evaluations of QY201 in future clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郑睿涛发布了新的文献求助10
1秒前
PMY完成签到,获得积分10
1秒前
Orange的应助被章鱼采纳,获得10
1秒前
2秒前
贪玩果汁发布了新的文献求助10
3秒前
3秒前
3秒前
wwwww完成签到,获得积分10
4秒前
tourist585发布了新的文献求助10
4秒前
乐乐的应助被qingxingzhou采纳,获得10
4秒前
酱紫完成签到 ,获得积分10
5秒前
8秒前
深情安青的应助被Xinghe1228采纳,获得30
8秒前
从未停步发布了新的文献求助20
9秒前
9秒前
完美世界的应助被叫你吃布丁采纳,获得10
9秒前
平静椰子完成签到,获得积分10
9秒前
wei发布了新的文献求助10
9秒前
greenandblue完成签到,获得积分10
10秒前
科研通AI2S的应助被花花采纳,获得10
10秒前
10秒前
葳蕤2发布了新的文献求助10
14秒前
lll发布了新的文献求助10
15秒前
15秒前
袁钢发布了新的文献求助10
16秒前
cyx发布了新的文献求助10
16秒前
希望天下0贩的0的应助被鸭梨采纳,获得10
16秒前
uilyang发布了新的文献求助10
16秒前
16秒前
TaoJ举报kye的求助涉嫌违规
17秒前
17秒前
18秒前
18秒前
banana的应助被欧阳万仇采纳,获得10
18秒前
郑睿涛发布了新的文献求助10
19秒前
零负一的应助被ZPC采纳,获得30
19秒前
贪玩果汁完成签到,获得积分10
20秒前
20秒前
英俊夜云完成签到,获得积分10
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183730
求助须知:如何正确求助?哪些是违规求助? 9572975
关于积分的说明 21828453
捐赠科研通 7780887
什么是DOI,文献DOI怎么找? 3434086
关于科研通互助平台的介绍 2558276
邀请新用户注册赠送积分活动 2480557